IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.811
-0.009 (-1.15%)
Nov 21, 2024, 10:52 AM EST - Market open

IO Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
24.3123.6124.4411.081.681.98
Research & Development
72.1167.8346.9930.158.467.94
Operating Expenses
96.4291.4471.4241.2310.159.91
Operating Income
-96.42-91.44-71.42-41.23-10.15-9.91
Interest Expense
---0.3-0.36-0.03-0.01
Interest & Investment Income
5.955.881.41---
Currency Exchange Gain (Loss)
1.480.330.130.320.11-0.04
EBT Excluding Unusual Items
-88.99-85.23-70.19-41.28-10.06-9.96
Other Unusual Items
----26.54-1.99-0.78
Pretax Income
-88.99-85.23-70.19-67.81-12.04-10.74
Income Tax Expense
1.350.851.270.07--
Net Income
-90.34-86.08-71.46-67.88-12.04-10.74
Preferred Dividends & Other Adjustments
---7.112.551.77
Net Income to Common
-90.34-86.08-71.46-74.99-14.59-12.52
Shares Outstanding (Basic)
664429400
Shares Outstanding (Diluted)
664429400
Shares Change (YoY)
92.75%51.10%564.62%2346.74%--
EPS (Basic)
-1.37-1.98-2.48-17.30-82.36-70.64
EPS (Diluted)
-1.37-1.98-2.48-17.30-82.36-70.64
Free Cash Flow
--72.06-60.42-40.8-9.96-8.89
Free Cash Flow Per Share
--1.66-2.10-9.41-56.19-50.17
EBITDA
-96.16-91.23-71.32-41.23--
D&A For EBITDA
0.250.220.10--
EBIT
-96.42-91.44-71.42-41.23-10.15-9.91
Source: S&P Capital IQ. Standard template. Financial Sources.